Dabigatran etexilate is taken with or after meals, and this product may prevent stroke and systemic embolism and should be used as directed by a physician. The usual dosage form of dabigatran etexilate is capsules. Common adverse reactions to this product can be seen as gastrointestinal bleeding, diarrhea, abdominal pain, nausea, dyspepsia, nosebleeds, and anemia. Therefore, the instructions state that the product should be swallowed whole with water during or after meals to minimize gastrointestinal irritation. Dabigatran etexilate can inhibit thrombin and exert anticoagulant activity to prevent thrombosis. It is used for the prevention of systemic embolism in surviving adults with non-valvular atrial fibrillation, as well as stroke. The drug is contraindicated in people who are allergic to the components of the product, severe renal impairment, significant active bleeding. It should be used under the guidance of a physician, and the detection of adverse reactions is recommended to consult a doctor in time to avoid delaying the disease.